Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

After washing the affected area, the wart should be soaked in comfortably warm water for 5 minutes. Following this, the area must be dried thoroughly. One drop of gel should be applied at a time to ensure sufficient coverage of each wart. The gel should be allowed to dry completely.

This procedure should be repeated once or twice daily until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on moles, birthmarks, and warts with hair growing from them is prohibited due to the potential for adverse reactions.

• The product should not be applied to mucous membranes, including the nose, anus, genitals, and lips, as these areas are sensitive and may lead to complications.

• Avoid use on irritated, infected, or reddened skin to prevent exacerbation of these conditions.

• The product is contraindicated for genital warts and warts located on the face, as these areas require specialized treatment.

• Individuals with diabetes or poor blood circulation should not use this product unless under the guidance and supervision of a healthcare professional, due to increased risk of complications.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from fire and flame to prevent any risk of ignition.

The product should not be applied to moles, birthmarks, or warts that have hair growing from them. Additionally, it is contraindicated for use on mucous membranes, including the nose, anus, genitals, and lips. Application on irritated, infected, or reddened skin is also prohibited. The use of this product is not recommended for genital warts or warts located on the face.

Patients with diabetes or poor blood circulation should avoid using this product unless under the guidance and supervision of a qualified healthcare professional, such as a doctor or podiatrist.

In the event that the product comes into contact with the eyes, it is crucial to flush the eyes with water for at least 15 minutes. Users should also take care to avoid inhaling vapors during application.

This product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

If discomfort persists after use, it is advisable for the patient to consult their doctor or podiatrist for further evaluation and management.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is for external use only and is flammable; therefore, it should be kept away from fire and flame.

It is contraindicated for use on moles, birthmarks, and warts with hair growing from them, as well as on mucous membranes, including the nose, anus, genitals, and lips. Additionally, it should not be applied to irritated, infected, or reddened skin, nor on genital warts or warts on the face. Patients who are diabetic or have poor blood circulation should only use this product under the advice and supervision of a doctor or podiatrist.

While using this product, if it comes into contact with the eyes, it is essential to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

This product should be kept out of reach of children. In the event of accidental ingestion, it is crucial to seek medical help or contact a Poison Control Center immediately. If discomfort persists during use, patients are advised to consult their doctor or podiatrist for further evaluation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover gel). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of Salicylic Acid wart remover gel during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no documented safety concerns, dosage modifications, or special precautions outlined for this population. Given the lack of information, healthcare professionals are advised to exercise caution when considering the use of this product in women of childbearing potential. It is recommended that pregnant patients consult their healthcare provider before using Salicylic Acid wart remover gel to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on moles, birthmarks, or warts that have hair growing from them, as well as to avoid application on mucous membranes, including the nose, anus, genitals, and lips.

Patients should be cautioned against using the product on irritated, infected, or reddened skin, and specifically on genital warts or warts located on the face. Additionally, healthcare providers should inform patients that the product should not be used if they are diabetic or have poor blood circulation, unless under the guidance and supervision of a doctor or podiatrist.

While using the product, patients should be advised to take precautions to prevent the product from getting into their eyes; if this occurs, they should flush the eyes with water for 15 minutes. It is also essential to instruct patients to avoid inhaling vapors from the product. If any discomfort persists, patients should be encouraged to consult their doctor or podiatrist for further evaluation and management.

Storage and Handling

The product is supplied in configurations that adhere to the specified NDC numbers. It is essential to store the product in a controlled environment, maintaining a temperature range between 59°F to 86°F (15°C to 30°C).

Care should be taken to keep the product away from fire and flame to ensure safety and integrity. Proper handling and storage conditions are crucial for maintaining the quality of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)